dsip nasal spray for sleep 6mg 15mL DSIP: The Sleep Peptide That

In a 2018 study published in Current Pharmaceutical Design , researchers compared the effectiveness of BPC-157 to that of various standard peptidergic angiogenic growth factors (EGF, FGF, and VEGF) and numerous carriers for treating gastrointestinal ulcer healing and tendon, ligament, muscle, and bone healing

While researchers usually administer BPC-157 and TB-500 via injections, there are now nasal spray blends on the market

Phase 2 dose-finding data The phase 2 trial tested cagrilintide at 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg weekly

Designed for scientific studies focused on neuroprotection, cognitive function, and stress response mechanisms, each 15 ml bottle delivers a stable peptide solution manufactured under strict quality controls and tested for purity and consistency

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance